The Impact of Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer’s Perspective

2010, Vol. 3 No. 12Articles International In-house Counsel Journal
The newly enacted federal health care reform legislation includes significant anti-fraud measures as well as additional funding to fight fraud and abuse. Such increased scrutiny on pharmaceutical promotional practices requires pharmaceutical manufacturers to pay close attention to and comply with the heath care laws, regulations and guidelines. The article examines the path to compliance.